Hua Ying Wang (Huaying Wang)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Sentinel Lymph Node

Top Venues

Journal of gynecologic oncology

Journal of oncology

Cancer medicine

International journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Ting Yan Shi, Libing Xiang, Jian Qing Zhu, Ji-Hong Liu, Ping Zhang, Hua Ying Wang, Yanling Feng, Tao Zhu, Yingli Zhang, Aijun Yu, Wei Jiang, Xipeng Wang, Yaping Zhu, Sufang Wu, Yincheng Teng, Jiejie Zhang, Rong Jiang, Wei Zhang, Huixun Jia, Rong Yu Zang
Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study. Journal of gynecologic oncology 33 (4) (2022)
Jun Guan, Yu Xue, Rong Yu Zang, Ji Hong Liu, Jian Qing Zhu, Ying Zheng, Bo Wang, Hua Ying Wang, Xiao-Jun Chen
Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial). Journal of gynecologic oncology 32 (4) (2021)
Wenjuan Tian, Boer Shan, Yuzi Zhang, Yulan Ren, Shanhui Liang, Jing Zhao, Zhengyi Zhao, Guoqiang Wang, Xiaochen Zhao, Dongxian Peng, Rui Bi, Shangli Cai, Yuezong Bai, Hua Ying Wang
Association between DNA damage repair gene somatic mutations and immune-related gene expression in ovarian cancer. Cancer medicine 9 (6) (2020)
Yuan Cheng, Yangyang Dong, Wenjuan Tian, Hua Zhang, Xiaoping Li, Zhiqi Wang, Boer Shan, Yulan Ren, Lihui Wei, Hua Ying Wang, Jianliu Wang
Nomogram for Predicting Recurrence-Free Survival in Chinese Women with Endometrial Cancer after Initial Therapy: External Validation. Journal of oncology 2020 (2020)
Wenjuan Tian, Rui Bi, Yulan Ren, Hongsheng He, Shanfu Shi, Boer Shan, Wentao Yang, Qing Wang, Hua Ying Wang
Screening for hereditary cancers in patients with endometrial cancer reveals a high frequency of germline mutations in cancer predisposition genes. International journal of cancer 145 (5) (2019)